Erythropoietin (EPO)
Kidney hormone that stimulates the bone marrow to produce red blood cells
Also known as
Definition
Erythropoietin, or EPO, is a hormone made by the kidneys. It signals the bone marrow to produce red blood cells. When too little oxygen reaches the body's tissues, for example with chronic obstructive pulmonary disease (COPD), more EPO can be produced. The blood test measures the EPO concentration and mainly helps to classify a high red blood cell count: whether it starts in the bone marrow itself (primary form, such as polycythemia vera) or results from another condition (secondary form).
| Parameter | Value |
|---|---|
| Unit | IU/l (= U/l) |
| Reference Range | There is no universal reference range, because it depends on the assay method. The pathology society RCPA gives about 5–25 IU/l as a rough guide. The range printed on your own report is what counts. Your doctor interprets the result. |
Agree on your personal target range with your doctor.
EPO is reported in international units per litre (IU/l or U/l). Arithmetically, 1 IU/l equals exactly 1 mIU/ml (also written mU/ml).
↓ What a low value means
A low EPO level can occur with polycythemia vera, a bone marrow disorder in which too many red blood cells are produced; a reduced EPO level is one of its diagnostic criteria. Chronic kidney disease and anemia of chronic disease also go along with a low or inadequate EPO level: damaged kidneys make less EPO, and the body produces fewer red blood cells. What a single value means depends on the full blood count and other findings. Your doctor interprets the result.
↑ What a high value means
A raised EPO level can occur with secondary erythrocytosis (polycythemia). Here another condition causes more EPO to be produced and therefore more red blood cells, for example a lack of oxygen in the tissues (hypoxia). Male sex hormones taken from outside the body (androgens) and rare EPO-producing tumors, for example of the kidney, are also possible causes. Your doctor interprets the result together with hemoglobin, hematocrit, red blood cell count and other findings.
When to test
The test is ordered specifically, mainly to investigate a high red blood cell count and to tell polycythemia vera apart from secondary forms. When polycythemia vera is suspected, EPO is one of the required lab tests. The test uses a blood sample.
Frequently asked questions
Why can EPO be low with kidney disease? +
Healthy kidneys make EPO, which stimulates the bone marrow to produce red blood cells. When the kidneys are damaged, they make less EPO, and the body produces fewer red blood cells. This is one of the causes of anemia in chronic kidney disease.
Why is EPO useful when the red blood cell count is high? +
In polycythemia vera, the bone marrow produces red blood cells without following the normal control mechanisms; a reduced EPO level is one of the diagnostic criteria. In secondary forms, for example as a result of a lack of oxygen, the EPO level can instead be raised. The diagnosis also relies on other findings, such as a genetic test for JAK2 mutations.
Can a stay at high altitude play a role? +
It can. A chronic lack of oxygen, for example after a longer stay in high mountains, can lead the body to produce more red blood cells. In this kind of secondary erythrocytosis caused by a lack of oxygen, the EPO level can be raised. A longer stay at high altitude before the blood draw therefore matters for interpreting the result.
Can medicines change the EPO level or the blood count? +
Yes. Androgens taken from outside the body, that is male sex hormones such as testosterone, can go along with a raised EPO level. There are also medicines that signal the bone marrow to make more red blood cells (erythropoiesis-stimulating agents); they are used, for example, for anemia caused by chronic kidney disease. For the interpretation it therefore matters which medicines you take.
Erythropoietin (EPO)
Sources
- Royal College of Pathologists of Australasia: RCPA Manual, Erythropoietin
- NIDDK, National Institutes of Health: Anemia in Chronic Kidney Disease
- NHS: Erythrocytosis
- DGHO (German Society of Hematology and Medical Oncology), Onkopedia guideline: Polycythaemia Vera (PV) (2023, in German)
- DGHO (German Society of Hematology and Medical Oncology), Onkopedia guideline: Eisenmangel und Eisenmangelanämie (2025, in German)
- IQWiG, Gesundheitsinformation.de: Erythrozyten (in German)
Last updated: October 05, 2026
This information is for orientation only and does not replace medical advice. Reference ranges can vary by laboratory, method and country.